Integrating Novel and Classical Prognostic Factors in Locally Advanced Cervical Cancer: A Machine Learning-Based Predictive Model (ESTHER Study)
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background/Objective: This study aimed to assess the prognostic significance of pretreatment nutritional and systemic inflammatory indices (IIs), and body composition parameters in patients with locally advanced cervical cancer (LACC) treated with chemoradiation and brachytherapy. The goal was to identify key predictors of clinical outcomes, such as local control (LC), metastasis-free survival (MFS), disease-free survival (DFS), and overall survival (OS), using machine learning techniques. Materials and methods: A retrospective analysis of 173 patients with LACC treated between 2007 and 2021 was conducted. The study utilized machine learning techniques, including LASSO regression and Classification and Regression Tree (CART) analysis, to identify significant predictors of outcomes. Clinical data, tumor-related parameters, and treatment factors, along with IIs and body composition metrics (e.g., sarcopenic obesity), were incorporated into the models. Model performance was evaluated using ROC curves and AUC values. Results: Among 173 patients, hemoglobin (Hb) levels, ECOG performance status, and total protein emerged as primary prognostic indicators across multiple endpoints. For 2-year LC, patients with Hb > 11.9 g/dL had a rate of 95.1% compared to 73.6% in those with lower levels, with further stratification by ECOG status, ANRI, and total protein refining predictions. For 5-year LC, rates were 83.1% for Hb > 11.5 g/dL and 43.3% for lower levels. For 2-year MFS, ECOG 0 patients had an 88.1% rate compared to 73.8% for ECOG ≥ 1. In 2-year OS, Hb > 11.9 g/dL predicted a 95.1% rate, while ≤11.9 g/dL correlated with 74.0%. IIs (ANRI, SIRI, MLR) demonstrated predictive value only within specific patient subgroups defined by the primary prognostic indicators. The model showed strong predictive accuracy, with AUCs ranging from 0.656 for 2-year MFS to 0.851 for 2-year OS. Conclusions: These findings underscore the value of integrating traditional prognostic factors with emerging markers to enhance risk stratification in LACC. The use of machine learning techniques like LASSO and CART demonstrated strong predictive capabilities, highlighting their potential to refine individualized treatment strategies. Prospective validation of these models is warranted to confirm their utility in clinical practice.
Source: Journal of Personalized Medicine
DOI: 10.3390/jpm15040153
Authors: Federica Medici, Martina Ferioli, Arina Alexandra Zamfir, Milly Buwenge, Gabriella Macchia, Francesco Deodato, Paolo Castellucci, Luca Tagliaferri, Anna Myriam Perrone, Pierandrea De Iaco, Lidia Strigari, Alberto Bazzocchi, Stefania M. R. Rizzo, Costanza Maria Donati, Alessandra Arcelli, Stefano Fanti, Alessio Giuseppe Morganti, Savino Cilla
Institutions: Institut Gustave Roussy, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Ferrara, Arcispedale Sant'Anna, University of Bologna, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto Ortopedico Rizzoli, Ente Ospedaliero Cantonale, Istituto Imaging della Svizzera Italiana
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: locally advanced cervical cancer, prognostic factors, systemic inflammatory index, body composition, sarcopenic obesity, hemoglobin, ECOG performance status, total protein, Siri, chemoradiotherapy, brachytherapy, local control, metastasis-free survival, disease-free survival, overall survival, risk stratification, machine learning prediction models, LASSO, classification and regression trees
Open Access status: gold
Estimated APC paid: $3,137
Funder: Ministero della Salute
Award: G3857299699
OpenAlex ID: W4409480930
